Cardiology

Total antioxidant status reduction conditioned by a serum selenium concentration decrease as a mechanism of the ultrasonographically measured brachial artery dilatation impairment in patients with arterial hypertension.



Related Articles

Total antioxidant status reduction conditioned by a serum selenium concentration decrease as a mechanism of the ultrasonographically measured brachial artery dilatation impairment in patients with arterial hypertension.

Environ Toxicol Pharmacol. 2020 Jan 24;75:103332

Authors: Gać P, Urbanik D, Pawlas N, Poręba M, Martynowicz H, Prokopowicz A, Januszewska L, Markiewicz-Górka I, Jaremków A, Mazur G, Poręba R, Pawlas K

Abstract
The objective of the study was to determine the relationship between serum concentrations of selenium (SeS) and zinc (ZnS), total antioxidant status (TAS) and endothelial function assessed by ultrasonographic method of dilatation of the brachial artery in 141 hypertensive patients. Patients with SeS < median were characterized by a statistically significantly lower flow-mediated dilation (FMD) than patients with SeS ≥ median. Patients with TAS < median were characterized by a significantly lower FMD than patients with TAS ≥ median. Older age, higher BMI, male gender, higher blood total cholesterol, ischemic heart disease, smoking and lower SeS constitute independent predictors of inferior endothelial function, expressed in lower FMD values. Smoking is an independent predictor of lower TAS, and the use of β-blockers and higher serum selenium levels are independent predictors of higher TAS. In summary, a decrease in TAS should be considered as a mechanism of inferior endothelial function in hypertensive patients conditioned by a decrease in SeS.

PMID: 32006877 [PubMed – as supplied by publisher]

Source link





Related posts

Slower Skeletal Muscle Oxygenation Kinetics in Adults With Complex Congenital Heart Disease.

Newsemia

Relationship of quantitative flow ratio after second-generation drug-eluting stent implantation to clinical outcomes.

Newsemia

Rituximab prevents and reverses cardiac remodeling by depressing B cell function in mice.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy